A detailed history of ETF Managers Group, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 2,818 shares of BIO stock, worth $951,723. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,818
Previous 3,640 22.58%
Holding current value
$951,723
Previous $1.53 Million 11.89%
% of portfolio
0.05%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$418.69 - $503.0 $344,163 - $413,466
-822 Reduced 22.58%
2,818 $1.35 Million
Q4 2022

Mar 23, 2023

BUY
$351.71 - $456.01 $137,166 - $177,843
390 Added 12.0%
3,640 $1.53 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $276,847 - $377,947
-671 Reduced 17.11%
3,250 $1.36 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $312,049 - $401,888
673 Added 20.72%
3,921 $1.95 Million
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $536,110 - $751,599
-1,022 Reduced 23.93%
3,248 $1.89 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $610,311 - $684,219
861 Added 25.26%
4,270 $3.24 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $1.43 Million - $1.79 Million
-2,167 Reduced 38.86%
3,409 $2.55 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $129,167 - $145,384
-224 Reduced 3.86%
5,576 $3.6 Million
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $164,103 - $198,705
-300 Reduced 4.92%
5,800 $3.27 Million
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $155,246 - $195,608
304 Added 5.24%
6,100 $3.51 Million
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $1.58 Million - $1.86 Million
3,471 Added 149.29%
5,796 $2.99 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $778,572 - $1.15 Million
2,325 New
2,325 $1.01 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.32B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.